Steven T. Boyd to Speak at PBM Contracting Summit
Presentation offers insights into legislative issues and the evolving PBM regulatory horizonNatchitoches, Louisiana--(Newsfile Corp. - December 9, 2024) - Steven...
Year: 2024
NEFHSC, Baptist Health & Philips Give Local Families Free Pregnancy+ App
JACKSONVILLE, Fla.--(BUSINESS WIRE)--To help ensure more families have access to educational resources they need for healthy birth outcomes, the Northeast...
NEFHSC, Baptist Health & Philips Give Local Families Free Pregnancy+ App
JACKSONVILLE, Fla.--(BUSINESS WIRE)--To help ensure more families have access to educational resources they need for healthy birth outcomes, the Northeast...
Theralase(R) Launches Three New Clinical Study Sites in USA
Associated Medical Professionals of NY, Urology of Indiana and Central Ohio Urology Group are the latest three US-based study sites...
Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus
FORT LAUDERDALE, FL / ACCESSWIRE / December 9, 2024 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering...
Tonix’s TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers
This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding...
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens
Intends to accelerate broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue streamLEXINGTON, Mass., Dec....
MAPS Launches ‘Music is the Bridge’ Campaign Featuring Lil Yachty, Melissa Etheridge, Reggie Watts and More
Artist-Curated Playlists and Psychedelic Education Come Together to Inspire Safe, Intentional ExplorationWASHINGTON, Dec. 09, 2024 (GLOBE NEWSWIRE) -- The Multidisciplinary...
Pluri Shortlisted for CDMO of the Year Award by Advanced Therapies Awards 2025
PluriCDMO™, the Company’s contract development and manufacturing organization, recognized as a leading manufacturing collaborator offering scalability and mass scale production...
Sonnet BioTherapeutics Announces Topline Safety Data Following Successful Completion of SON-1010 Monotherapy Dose Escalation in Phase 1 SB101 Trial
The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg, without dose-limiting toxicity or evidence of cytokine release...
SELLAS Announces Positive Overall Survival and Overall Response Rate Data from the Phase 2 Trial of SLS009 in r/r AML
- Median Overall Survival (mOS) Not Yet Reached, Now Exceeds 7.7. Months at Latest Follow-Up in the 30 mg BIW...
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer
SEATTLE and VANCOUVER, British Columbia, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...
Gelteq to Participate in the Benchmark Company 13th Annual Discovery Investor Conference
NEW YORK, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based...
Safety Shot Announces Online Retail Expansion with one of the US Largest Big Box Store’s E-Commerce Platform
JUPITER, Fla., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or “the Company”) today announced...
China’s NMPA Approves EOM’s Coronary Imaging System Based on Conavi Medical’s IP
– Approval triggers fourth and final US$5.9 million milestone payment to Conavi Medical, which it will use to extinguish the...
aTyr Pharma to Present Preclinical Research Demonstrating Anti-Fibrotic Effects of ATYR0101 in Lung and Kidney Fibrosis at Keystone Symposia on Fibrosis
ATYR0101 interacts with LTBP-1 to induce myofibroblast apoptosis through a novel anti-fibrotic mechanism to reduce fibrosis and fibrotic markers in...
Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia
WARRINGTON, Pa., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company...
BetterLife Announces Favorable Outcome in New York Legal Claims
VANCOUVER, British Columbia, Dec. 09, 2024 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU),...
Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly
FDA Assigns a Prescription Drug User Fee Act Target Action Date of September 25, 2025SAN DIEGO, Dec. 09, 2024 (GLOBE...
Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision
DALLAS, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI)...